{"@id":"https://bioecon.ru/technology/ai-feasibility-edc-for-trials/","@type":"Technology","cluster":"digital-it","formats":{"html":"https://cn.bioecon.ru/technology/ai-feasibility-edc-for-trials/","json":"https://cn.bioecon.ru/api/v1/technology/ai-feasibility-edc-for-trials/index.json"},"id":"ai-feasibility-edc-for-trials","industries":["digital-robotics","bio-ai","pharma","services"],"lang":"cn","links":{"industries":["https://bioecon.ru/industries/digital-robotics/","https://bioecon.ru/industries/bio-ai/","https://bioecon.ru/industries/pharma/","https://bioecon.ru/industries/services/"],"suppliers":["https://bioecon.ru/companies/genmab/","https://bioecon.ru/companies/insilico-medicine/","https://bioecon.ru/companies/fresenius/","https://bioecon.ru/companies/biohaven/","https://bioecon.ru/companies/recursion-pharmaceuticals/","https://bioecon.ru/companies/esco-aster/","https://bioecon.ru/companies/zamseed/","https://bioecon.ru/companies/mgi/","https://bioecon.ru/companies/chenot/","https://bioecon.ru/companies/imperagen/"]},"maturity":8,"name":"基于真实世界EHR大数据的AI临床研究中心可行性评估与自适应EDC集成系统","regions":["ch","eu","us","cn"],"risk":"low","section":"technology","sector":"services-governance-capital","sources":[{"date":"2026-11-22","entity":"Swiss Biotech Directory 2026","kind":"vendor","urls":["https://www.swissbiotech.org/directory/"]}],"stages":[{"n":1,"title":"联邦去标识化医院电子病历真实受试者存量透视"},{"n":2,"title":"研究中心过往执行力与竞品试验竞争密度综合评级"},{"n":3,"title":"方案参数驱动的自适应eCRF表单与校验规则自动编译"},{"n":4,"title":"临床研究中心立项与伦理审查进度数字化流水线管理"}],"summary":"通过深度连通全球多国医院网络去隐私化电子病历（EHR）大数据的AI临床中心可行性评价与自适应EDC套件。系统可在数秒内精准穿透分析候选研究中心符合特定生化指标与基因突变的真实目标患者存量、PI过往方案执行效率及竞争试验拥挤度，输出最优研究中心推荐名单；并根据试验方案自动编译生成动态逻辑校验电子病例报告表（eCRF），显著压缩试验启动周期（Study Startup）。","url":"/technology/ai-feasibility-edc-for-trials/","verified":"2026-11-22"}